‘The label should be changed’: HHS Sec Kennedy pledges to review FDA approval of abortion drug

CV NEWS FEED // Health and Human Services Secretary Robert F. Kennedy, Jr. said Wednesday that he has ordered a top-down review of the abortion drug mifepristone in light of “alarming” research showing the Food and Drug Administration (FDA)-approved pill does far more harm to women than previously reported. The latest research is “alarming,” Kennedy said during a hearing before the Senate Health, Education, Labor and Pensions Committee. “And clearly it indicates at the very least the [FDA] label should be changed.” “I’ve asked Marty Makary, who’s the director of the FDA, to do a complete review and to report...